Yufeng Xi, Yujia Wang, & Yujia Wang. (2022). IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma? Frontiers Media S.A..
Chicago Style (17th ed.) CitationYufeng Xi, Yujia Wang, and Yujia Wang. IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma? Frontiers Media S.A., 2022.
MLA (9th ed.) CitationYufeng Xi, et al. IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma? Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.